Over $80M BARDA Prize to Create New H5N1 Vaccines to Prepare for “Future” Bird Flu Pandemic
The Biomedical Advanced Research and Development Authority (BARDA) has launched an $80+ million multi-stage competition for “vaccine developers and researchers, biotech companies, and other innovators” to develop vaccines for pandemic influenza A, or A(H5) bird flu, which includes highly pathogenic avian influenza A(H5N1). The name of the competition is Single Shield Prize, and it “calls […]
Government Investigation Examines Potential Link Between COVID Shots and Troop Deaths
Army Lieutenant Colonel Theresa Long said in a Virginia federal court that she is reviewing 55,000 troop adverse-event reports and 2,544 troop death reports to determine if any were linked to COVID-19 shots.1 Dr. Long, a board-certified aerospace medicine physician and flight surgeon who holds a master’s degree in public health, said in an Aug. […]
Public Confidence in Measles Vaccine Falls in U.S.
Public confidence in the safety of measles vaccines has declined in the United States, according to a new Reuters/Ipsos poll. The survey found that 76 percent of people in the U.S. consider the measles, mumps and rubella (MMR) vaccine safe for children. That figure was 84 percent in a similar Reuters/Ipsos poll conducted in May […]
Graphene Oxide Being Tested on Animals as an Adjuvant in Vaccines
Graphene oxide (GO) is a material made from graphene, a very thin form of carbon, with oxygen added to its structure. Scientists have studied GO for possible medical uses, including its use as an ingredient in vaccines. Other researchers have examined what happens when GO comes into contact with human cells. A review published in […]
Measles Transmission by Vaccinated People Documented in Medical Literature
A new systematic review and meta-analysis published in the peer reviewed medical literature confirmed that people who have received measles-containing vaccines can become infected with measles and transmit the infection to others, contributing to measles outbreaks around the world. The study, which was published Aug. 14, 2026 in Expert Review of Vaccines, screened 5,240 peer-reviewed […]
Moderna/Merck Personalized mRNA Melanoma Cancer Shot Uses AI-Generated Design
A personalized mRNA melanoma cancer shot developed by Moderna and Merck using an AI generated design has met the primary endpoint in a late-stage phase 3 clinical trial.1 In August, the two pharmaceutical giants reported that, when combined with an existing treatment, the vaccine reduced the risk of melanoma returning or spreading. Cancer experts are enthusiastic […]